Does Triamcinolone Acetonide Interact with Antimalarials Chloroquine Primaquine?
CDI records a moderate classification for Triamcinolone Acetonide and Antimalarials Chloroquine Primaquine. The stored summary is: Increased risk of methemoglobinemia when concurrently exposed to antimalarials. The mechanism involves risk of methemoglobinemia development. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Triamcinolone Acetonide Class
- Corticosteroid
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Risk of methemoglobinemia development
What To Tell Your Doctor or Pharmacist
If you are taking Triamcinolone Acetonide and your doctor is considering prescribing Antimalarials Chloroquine Primaquine (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider